COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-
生长因子和癌基因产物在肝癌发生和肝脏再生中的协同作用-双转基因小鼠分析-
基本信息
- 批准号:09670510
- 负责人:
- 金额:$ 2.18万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Transforming growth factor(TGF)alpha and protooncogene ras are involved inthe intracellular signal transduction through the activation of tyrosine kinase.We and other group have developed TGFalpha transgenic mice(T) and ras transgenicmice(R) independently, Both of the transgenic mice showed characteristicphenotypes e.g. hepatocellular carcinoma, pancreatic fibrosis for (T) andsplenic sarcoma and skin papilloma for (R). We made the double transgenic miceof TGFalpha and ras(T+R) and analyzed the phenotype, tumor formation, and liverregeneration. First of all, T+R had lower body weight than T and R and the rate ofliver weight! body weight was significantly higher in T+R than single T or R.Large hepato cellular carcinoma and adenoma were observed in 4 of 15 T+R 12months after birth. Four of 15(R) developed skin papilloma and 2 of 15 (T) didhepatic adenoma. More than 10% of hepatocytes were positively stained byproliferating cell nuclear antigen(PCNA) in liver tumors of T+R and about 1% ofnon-tumor tissue of T+R.On the other hand, non-tumor liver showed less than1% by PCNA.Compared with T and R, T+R showed enhanced regeneration of theliver after 2/3 hepatectomy. Skin tumor and splenic sarcoma was not enhancedin T+R compared with R.he weight of pancreas was heavier in T+R than T or Rand pancreatic fibrosis was enhanced in T+R than T or R.Thus simultaneous overexpression of TGFa and ras inhibited the growth ofthe mice and enhanced the growth of the liver, hepatic tumor formation andregeneration. Pancreatic fibrosis was also enhanced by TGFalpha and ras, resultingin enhanced growth of pancreas.
转化生长因子(TGF)α和原癌基因ras通过酪氨酸激酶的激活参与细胞内信号转导。我们和其他课题组独立培育了TGFα转基因小鼠(T)和ras转基因小鼠(R),两种转基因小鼠均表现出特征性表型例如肝细胞癌、胰腺纤维化(T),脾肉瘤和皮肤乳头状瘤(R)。我们制作了TGFα和ras(T+R)双转基因小鼠,并分析了其表型、肿瘤形成和肝脏再生。首先,T+R的体重和肝重率均低于T和R! T+R组体重明显高于单次T或R组。出生后12个月,15例T+R组中有4例出现大肝细胞癌和腺瘤。 15 名 (R) 中的 4 名出现皮肤乳头状瘤,15 名 (T) 中的 2 名出现双肝腺瘤。 T+R肝肿瘤组织中10%以上肝细胞呈增殖细胞核抗原(PCNA)阳性,T+R非肿瘤组织中约1%肝细胞呈增殖细胞核抗原(PCNA)阳性。 PCNA。与T和R相比,T+R显示2/3肝切除后肝脏再生增强。与R相比,T+R中皮肤肿瘤和脾肉瘤没有增强。T+R中胰腺重量比T或R重,并且T+R中胰腺纤维化比T或R中增强。因此TGFa和ras同时过表达受到抑制促进小鼠的生长并增强肝脏的生长、肝肿瘤的形成和再生。 TGFα 和 ras 也可增强胰腺纤维化,从而促进胰腺生长。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takagi H,et al.: "The effects high dose intereron-α in patients with hepatitis C-in view of hypervariable of HCV-." FIRST INTERNATIONAL SYMPOSIUM ON VIRAL HEPATITIS.supple.1.Supple.7-10 (1998)
Takagi H 等人:“考虑到 HCV 的高变性,高剂量 Intereron-α 对丙型肝炎患者的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takayama H,et al: "Analysis of the hepatic and gastrointestinal phenotype of HGF/SF transgenic mice.(in Japanese)" Frontiers in Gastroenterology. 2. 252-260 (1997)
Takayama H 等人:“HGF/SF 转基因小鼠的肝脏和胃肠道表型分析。(日语)”胃肠病学前沿。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sohara N,et al.: "Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrchrolide."
Sohara N,et al.:“肝细胞癌患者动脉化疗栓塞引起的恶心和呕吐以及盐酸昂丹司琼的止吐作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takagi H, et al: "Prediction of the effect of interferon to chronic hepatitis C." Digestive Diseases and Sciences. 42(11). 2270-2276 (1997)
Takagi H 等人:“干扰素对慢性丙型肝炎的影响的预测”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ichikawa T,et al.: "Quantitative analysis of hepatitis B virus precore mutant in hepatitis B." TOHOKU J Exp.Med.186. 323-333 (1998)
Ichikawa T 等人:“乙型肝炎病毒前核突变体的定量分析”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKAGI Hitoshi其他文献
TAKAGI Hitoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKAGI Hitoshi', 18)}}的其他基金
Development of low-cost extraction method for cellulose nanofiber from paper sludge and application to biocomposites
开发从造纸污泥中低成本提取纤维素纳米纤维的方法及其在生物复合材料中的应用
- 批准号:
24656394 - 财政年份:2012
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Clinical evidence-based investigation of developmental mechanism in diabetic retinopathy
糖尿病视网膜病变发生机制的临床循证研究
- 批准号:
23592594 - 财政年份:2011
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of nano cellulose fiber green composites fabricated by combining controlled solidification and freeze-drying
可控凝固与冷冻干燥相结合制备纳米纤维素纤维绿色复合材料的开发
- 批准号:
20560642 - 财政年份:2008
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combination therapy of apoptosis induction and molecular targeting for hepatocellular carcinoma. -Transgenic mice study-
细胞凋亡诱导和分子靶向联合治疗肝细胞癌。
- 批准号:
15590619 - 财政年份:2003
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The pathological investigation of proliferative diabetic retinopathy based on the control of retinal pericytes
基于视网膜周细胞控制的增殖性糖尿病视网膜病变的病理学研究
- 批准号:
12470363 - 财政年份:2000
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study on the production of high temperature supercomposites and strengthening by mesoscopic structural controlling
高温超级复合材料的制备及细观结构控制强化研究
- 批准号:
11650709 - 财政年份:1999
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ANALYSIS OF GASTRIC MUCOSAL PROLIFERATION USING THE GROWTH FACTOR TRANSGENIC MICE
使用生长因子转基因小鼠分析胃粘膜增殖
- 批准号:
11670475 - 财政年份:1999
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of gene therapy for retinal neovascular disorders by controlling expression of VEGF
通过控制 VEGF 表达开发治疗视网膜新生血管疾病的基因疗法
- 批准号:
09470378 - 财政年份:1997
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
THE STUDY OF SEX DIFFERENCE IN HEPATOCARCINOGENESIS-ANALYSIS USING TGF alpha TRANSGENIC MICE-
肝癌发生过程中性别差异的研究-使用TGFα转基因小鼠进行分析-
- 批准号:
07670562 - 财政年份:1995
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Is the U.S.Banking Industry in Decline?
美国银行业正在衰落吗?
- 批准号:
07630090 - 财政年份:1995
- 资助金额:
$ 2.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
ARAF调控RAS活性的分子机理与生物学功能研究
- 批准号:32370754
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
伊曲康唑抑制SH3TC2诱导RAS突变结直肠癌细胞铁死亡的机制研究
- 批准号:82303016
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FAM84B通过上调Ras棕榈酰化促进结直肠肿瘤干细胞肝转移的机制研究
- 批准号:82303545
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向难成药靶点K-Ras(G12D)共价抑制剂的设计与发现研究
- 批准号:22377033
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
从RAS系统对骨-血管轴的调控机制探索杜仲对RA和AS异病同治的性效内涵
- 批准号:82374052
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Conserved coamplification event in HER2+ breast cancer increases metastasis
HER2 乳腺癌中保守的共扩增事件会增加转移
- 批准号:
10603730 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function
开发一种非类固醇和非激素药物,可逆转更年期相关的生殖器上皮完整性和功能丧失
- 批准号:
10901049 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Post-translational regulation of aromatase in aging
衰老过程中芳香酶的翻译后调控
- 批准号:
10572625 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别:
Midbrain pathways for visual hypersensitivity in neurofibromatosis type 1
1 型神经纤维瘤病视觉超敏反应的中脑通路
- 批准号:
10733781 - 财政年份:2023
- 资助金额:
$ 2.18万 - 项目类别: